Related Experiment Video

Updated: May 19, 2026

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

NK cells: key to success of DC-based cancer vaccines?

Eva Lion1, Evelien L J M Smits, Zwi N Berneman

  • 1Vaccine & Infectious Disease Institute (Vaxinfectio), Laboratory of Experimental Hematology, TIGR, University of Antwerp (UA), Antwerp University Hospital (UZA), Wilrijkstraat 10, B-2650 Antwerp, Belgium. eva.lion@ua.ac.be

The Oncologist
|August 22, 2012
PubMed

Insights

Natural killer (NK) cells are crucial for effective cancer vaccines. Integrating NK cell monitoring and enhancement into dendritic cell (DC) vaccination strategies can improve antitumor immunity and clinical outcomes.

Area of Science:

  • Immunology
  • Cancer Research
  • Vaccinology

Background:

  • Natural killer (NK) cells possess cytotoxic and regulatory antitumor functions, making them key targets for cancer immunotherapy.
  • The interaction between NK cells and dendritic cells (DCs) is critical for developing effective antitumor immunity.

Purpose of the Study:

  • To review the role of NK cells in DC-based cancer vaccination strategies.
  • To explore methods for enhancing DC vaccine efficacy by leveraging NK cell functions.
  • To highlight the importance of NK cell monitoring in preclinical and clinical DC vaccination studies.

Main Methods:

  • Comprehensive overview of in vivo experimental and clinical DC vaccination studies.
  • Analysis of studies that included NK cell monitoring.
  • Discussion of strategies to improve DC vaccine preparation using NK cells.

Main Results:

  • NK cells play a significant regulatory role in DC-induced antitumor immunity.
  • Targeting both innate (NK cells) and adaptive immune mechanisms may synergistically improve clinical outcomes.
  • Current DC vaccination trials infrequently include NK cell monitoring.

Conclusions:

  • Exploiting NK cells can enhance DC vaccine preparations.
  • Relevant NK cell parameters should be summarized for immune monitoring.
  • DC-based cancer vaccine design must incorporate evaluation of NK cell-stimulating potency in preclinical and clinical settings.

More Related Videos

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells12:08

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells

Published on: May 17, 2019

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...